SEC Form 5 · accession 0001140361-18-008543
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry J Fuchs
Officer — President, Worldwide R&D
Period of report
Dec 31, 2017
Accepted (ET)
Feb 14, 2018 · 8:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 6, 2017 | G | 415 | $0.00 | D | 133,561 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 6, 2017, the reporting person gifted 415 shares to an educational institution.